$APRE Some are missing the huge significance of an FDA Partial Clinical Hold release. FDA iiscombing through all those trials on hold and the data. Several of these are alreasy approved Breakthrough Therapy and Fast Track Approval Designation cancer Treatment Therapies for $APRE Two of those Trials on hold had "Knock your socks off" results at end of Phase 2, and management was taking both of these to FDA for Breakthrough Therapy and Fast Track Approval in 2nd half of 2021. If they are deep diving in to all this trial information now and we come out on other side with a Partial Clinical Hold release, to me it would seem Approval of drug for treatment in these Phase 2's is more of just a formality. Wouldn't you tend to agree?